Home
Coverage
Amryt
Anixa Biosciences
Atomera
Fortress Bio
INmune Bio
Lantern Pharma
ParkerVision
Quest Resource Holding
Spectra7
TFF Pharmaceuticals
Members
Current Holdings & Performance
Trading Blog
Zoom Calls…
Newsletter
Monthly Performance Reviews
Weekly Newsletters
About
About
Contact Us
Privacy Policy
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Member Login
Login
Reset Password
Become a Member
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
TW Research Group
Home
Coverage
Amryt
Anixa Biosciences
Atomera
Fortress Bio
INmune Bio
Lantern Pharma
ParkerVision
Quest Resource Holding
Spectra7
TFF Pharmaceuticals
Members
Current Holdings & Performance
Trading Blog
Zoom Calls…
Newsletter
Monthly Performance Reviews
Weekly Newsletters
About
About
Contact Us
Privacy Policy
Disclaimer
Daniel Carlson
1938 POSTS
524 COMMENTS
Front Page
Quest Resource Holding Corporation Reports First Quarter 2022 Financial Results
Daniel Carlson
-
May 16, 2022
0
Front Page
INmune Bio Looks to Change The CNS Landscape. An Interview With...
Daniel Carlson
-
May 16, 2022
0
Front Page
It’s Still The Early Innings
Daniel Carlson
-
May 14, 2022
11
Front Page
Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor...
Daniel Carlson
-
May 13, 2022
0
Front Page
TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business...
Daniel Carlson
-
May 11, 2022
3
Front Page
INmune Bio, Inc. Presents Data Demonstrating XPro™ Promotes Remyelination in Gray...
Daniel Carlson
-
May 10, 2022
1
Anixa
Stepping on Rakes
Daniel Carlson
-
May 7, 2022
0
Front Page
INmune Bio, Inc. Announces First Quarter 2022 Results and Provides Business...
Daniel Carlson
-
May 5, 2022
0
Front Page
Top Global Virtual Reality Gaming Company Chooses Spectra7 Chipset to Power...
Daniel Carlson
-
May 5, 2022
0
Front Page
enVVeno Medical Reports First Quarter 2022 Financial Results and Provides Corporate...
Daniel Carlson
-
May 2, 2022
0
Front Page
TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin...
Daniel Carlson
-
May 2, 2022
0
Front Page
Spectra7 Announces Fourth Quarter and Fiscal Year 2021 Financial Results
Daniel Carlson
-
May 2, 2022
0
Anixa
The Rolling Correction Gathers Steam…
Daniel Carlson
-
April 30, 2022
3
Anixa
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the...
Daniel Carlson
-
April 28, 2022
2
Atomera
Atomera Provides First Quarter 2022 Results
Daniel Carlson
-
April 27, 2022
0
Atomera
Atomera Enters into Joint Development Agreement with Major Foundry
Daniel Carlson
-
April 27, 2022
0
Front Page
Does Nkarta’s Positive NK Data Have Any Relation To INmune Bio’s...
Daniel Carlson
-
April 25, 2022
0
Fortress Bio
Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106, CD20-Targeted...
Daniel Carlson
-
April 25, 2022
2
Amryt
It’s A Process
Daniel Carlson
-
April 23, 2022
7
Amryt
CHMP adopts positive opinion for Filsuvez® for the treatment of Dystrophic...
Daniel Carlson
-
April 22, 2022
0
Front Page
TFF Pharmaceuticals Announces Safety and Pharmacokinetic Data from Phase 1 Study...
Daniel Carlson
-
April 19, 2022
3
Front Page
Movano Hires Chief Marketing Officer to Implement Its Multi-Channel Marketing Strategy...
Daniel Carlson
-
April 18, 2022
0
Company
How’s Your Balance (Sheet)?
Daniel Carlson
-
April 16, 2022
8
Atomera
Atomera Successfully Meets Requirements of Joint Development Agreement
Daniel Carlson
-
April 14, 2022
1
Front Page
INmune Bio Announces First Patient Dosed in Phase 2 XPro1595 Trial...
Daniel Carlson
-
April 13, 2022
0
Amryt
Amryt Announces Positive Long-Term Safety and Efficacy Data for Mycapssa® (oral...
Daniel Carlson
-
April 13, 2022
0
Front Page
INmune Bio, Inc. to Present Preclinical Data on INB03 at the...
Daniel Carlson
-
April 12, 2022
0
Front Page
Your Home Is Worth What???
Daniel Carlson
-
April 9, 2022
5
Anixa
Anixa Zoom Recap
Daniel Carlson
-
April 7, 2022
1
Front Page
Spectra7 Announces Preliminary First Quarter 2022 Revenue and Provides Business Update
Daniel Carlson
-
April 7, 2022
0
Anixa
Anixa Biosciences’ Ovarian Cancer CAR-T Therapy to be Discussed at The...
Daniel Carlson
-
April 6, 2022
0
Front Page
All Coming Together
Daniel Carlson
-
April 5, 2022
0
Front Page
INmune Bio, Inc. Highlights INKmune™ Data Featured in NK Cells in...
Daniel Carlson
-
April 4, 2022
0
Front Page
The New Reality
Daniel Carlson
-
April 2, 2022
2
Anixa
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase...
Daniel Carlson
-
March 30, 2022
6
Front Page
Spectra7 Partners with Volex to Deliver Next Generation 800Gbps Data Center...
Daniel Carlson
-
March 30, 2022
0
Front Page
INmune Bio, Inc. Announces Company’s CSO Dr. Mark Lowdell to Co-Host...
Daniel Carlson
-
March 30, 2022
0
Front Page
enVVeno Medical Reports Fourth Quarter and Year-End 2021 Financial Results and...
Daniel Carlson
-
March 28, 2022
0
Front Page
Separating the Wheat From the Chaff
Daniel Carlson
-
March 26, 2022
8
Front Page
INmune Bio, Inc. Spotlights Key Findings in Presentations at AD/PD™ 2022
Daniel Carlson
-
March 25, 2022
0
Front Page
Movano Inc. Provides Business Update and Reports Fourth Quarter 2021 Financial...
Daniel Carlson
-
March 25, 2022
0
Front Page
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results...
Daniel Carlson
-
March 24, 2022
2
Front Page
Update on INmune, TFF Pharma and DarioHealth
Daniel Carlson
-
March 24, 2022
5
Fortress Bio
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate,...
Daniel Carlson
-
March 21, 2022
0
Front Page
Buy The Rumor, Sell The News
Daniel Carlson
-
March 19, 2022
3
Front Page
For Those Looking To Play A Bounce, Here’s A Candidate
Daniel Carlson
-
March 18, 2022
0
Front Page
TFF Pharmaceuticals Enters into CRADA with the U.S. Army and The...
Daniel Carlson
-
March 17, 2022
3
Front Page
INmune Bio, Inc. Announces Nine Data Presentations at AD/PD™ 2022 –...
Daniel Carlson
-
March 15, 2022
0
Anixa
Groundhog Day
Daniel Carlson
-
March 12, 2022
12
Front Page
Orlando Court Grants Qualcomm Motion Blocking ParkerVision’s Presentation of Key Evidence...
Daniel Carlson
-
March 11, 2022
2
Front Page
QUEST RESOURCE HOLDING CORPORATION ANNOUNCES STRONG PRELIMINARY FOURTH QUARTER 2021 FINANCIAL...
Daniel Carlson
-
March 10, 2022
0
Anixa
ANIX Update
Daniel Carlson
-
March 9, 2022
1
Front Page
One-Year VenoValve(R) Data Published in Peer-Reviewed Journal, Vascular and Endovascular Surgery
Daniel Carlson
-
March 9, 2022
0
Amryt
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
Daniel Carlson
-
March 9, 2022
0
Amryt
Amryt Announces Successful Bioavailability Study for Mycapssa® (octreotide capsules)
Daniel Carlson
-
March 8, 2022
0
Front Page
This Trend is NOT Your Friend
Daniel Carlson
-
March 5, 2022
8
Front Page
INmune, a very brief update
Daniel Carlson
-
March 4, 2022
3
Atomera
Atomera’s Enhanced MSTcad Helps Chip Companies Quickly Realize MST Benefits
Daniel Carlson
-
March 3, 2022
0
Front Page
TFF Pharmaceuticals and Catalent Announce New Inhalation Dry Powder Development and...
Daniel Carlson
-
March 1, 2022
3
Front Page
TFFP: More Thoughts Regarding NICLOSAMIDE
Daniel Carlson
-
February 28, 2022
3
Amryt
Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA
Daniel Carlson
-
February 28, 2022
0
Amryt
Putin It In Perspective
Daniel Carlson
-
February 25, 2022
7
Front Page
Positive Long-Term VenoValve® First-in-Human Data Presented at 34th Annual Meeting of...
Daniel Carlson
-
February 25, 2022
5
Front Page
TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of the...
Daniel Carlson
-
February 24, 2022
5
Front Page
Good News
Daniel Carlson
-
February 19, 2022
1
Front Page
enVVeno Medical Announces ISO 13485 Certification
Daniel Carlson
-
February 19, 2022
0
Front Page
Updating My Thinking On INmune (INMB) and TFF Pharma (TFFP)
Daniel Carlson
-
February 18, 2022
6
Front Page
Movano Completes its Second Glucose Pilot Study
Daniel Carlson
-
February 18, 2022
0
Front Page
Movano Announces Two Key Hires to Further Its Go-To-Market Strategy for...
Daniel Carlson
-
February 15, 2022
0
Atomera
End Game
Daniel Carlson
-
February 12, 2022
2
Atomera
Quest and Atomera Spike…Should You Be A Buyer?
Daniel Carlson
-
February 10, 2022
0
Atomera
Atomera Licenses MST® Technology to Semiconductor Foundry
Daniel Carlson
-
February 8, 2022
0
Front Page
Updates From Several Management Calls
Daniel Carlson
-
February 6, 2022
4
Atomera
Metamorphosis
Daniel Carlson
-
February 5, 2022
2
Front Page
This Week’s Billboard Headline…Glenn Mattes Stars As Rocky Balboa!
Daniel Carlson
-
January 29, 2022
6
Amryt
Amryt Announces Oleogel-S10 EMA Regulatory Update
Daniel Carlson
-
January 28, 2022
0
Front Page
Spectra7: Hyper-Growth in Hyper-Scale Data Centers
Daniel Carlson
-
January 27, 2022
0
Front Page
TFF Pharmaceuticals Completes Enrollment in Phase 1 Study Evaluating Inhaled Formulation...
Daniel Carlson
-
January 27, 2022
0
Front Page
INmune Bio, Inc. Announces Research Collaboration with Chinese University of Hong...
Daniel Carlson
-
January 25, 2022
0
Fortress Bio
Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of...
Daniel Carlson
-
January 25, 2022
0
Front Page
PTAB Issues Rulings in ParkerVision IPRs Filed by Intel
Daniel Carlson
-
January 25, 2022
0
Front Page
Spectra7 Announces Preliminary Fourth Quarter 2021 Revenue and Record Order Backlog...
Daniel Carlson
-
January 24, 2022
0
Front Page
Lantern Pharma Receives Rare Pediatric Disease and Orpan Drug Designations for...
Daniel Carlson
-
January 24, 2022
0
Anixa
Anixa Biosciences and MolGenie Announce Early Potency Analysis of SARS-CoV-2 Protease...
Daniel Carlson
-
January 24, 2022
0
Front Page
Welcome To The Terrordome
Daniel Carlson
-
January 22, 2022
3
Front Page
An INKmune Update, Catalysts Included…
Daniel Carlson
-
January 17, 2022
0
Anixa
ParkerVision’s Time is Nigh…
Daniel Carlson
-
January 15, 2022
4
Front Page
Lantern Pharma Expands Precision Oncology Collaboration with the National Cancer Institute...
Daniel Carlson
-
January 13, 2022
0
Fortress Bio
Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule...
Daniel Carlson
-
January 13, 2022
0
Amryt
Amryt Announces Positive Long-Term Safety and Efficacy Data confirming the role...
Daniel Carlson
-
January 11, 2022
0
Anixa
Welcome to 2022?
Daniel Carlson
-
January 8, 2022
6
Front Page
Movano Completes Blood Pressure Study with 110 Participants
Daniel Carlson
-
January 3, 2022
0
Amryt
Happy New Year!!!
Daniel Carlson
-
January 1, 2022
8
Front Page
Movano Unveils Smart Ring Designed for Women Seeking More Approachable Health...
Daniel Carlson
-
December 27, 2021
3
Front Page
Trading Blog, December 22, 2021
Daniel Carlson
-
December 22, 2021
0
Front Page
TFF Pharmaceuticals Announces Final Data from Phase 1b Study of Inhaled...
Daniel Carlson
-
December 21, 2021
1
Front Page
Who Believes? Santa Rally Coming…
Daniel Carlson
-
December 18, 2021
14
Front Page
Lantern Pharma Presents Positive Data on the Effectiveness of LP-284 in...
Daniel Carlson
-
December 14, 2021
0
Front Page
No QUESTion, This Stock’s A Winner
Daniel Carlson
-
December 11, 2021
4
Front Page
INmune Bio, Inc. Announces Key Breast Cancer Treatment Resistance Data to...
Daniel Carlson
-
December 9, 2021
0
Front Page
Quest Resource Holding Acquires Two Asset-Light Waste Services Companies
Daniel Carlson
-
December 8, 2021
0
Anixa
Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected...
Daniel Carlson
-
December 7, 2021
0
Fortress Bio
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of...
Daniel Carlson
-
December 7, 2021
0
Front Page
TFF Pharmaceuticals Hosting Science Day on December 13, 2021
Daniel Carlson
-
December 6, 2021
0
Anixa
Bottom Picking
Daniel Carlson
-
December 4, 2021
3
Front Page
INmune Bio, Inc. Announces Two Presentations at the 2021 British Society...
Daniel Carlson
-
December 1, 2021
0
Atomera
Atomera Breathes New Life into Moore’s Law for Power and Analog...
Daniel Carlson
-
November 30, 2021
0
Front Page
Is OMICRON Potentially Positive For TFF Pharma?
Daniel Carlson
-
November 29, 2021
8
Fortress Bio
Avenue Therapeutics Announces FDA Advisory Committee Meeting to Review IV Tramadol...
Daniel Carlson
-
November 29, 2021
0
Anixa
Turkey Shoot…December Preview
Daniel Carlson
-
November 26, 2021
2
Front Page
Trading Blog, November 23rd, 2021
Daniel Carlson
-
November 23, 2021
0
Amryt
Amryt Provides Update on Regulatory Review Process for Oleogel-S10
Daniel Carlson
-
November 23, 2021
0
Amryt
Amryt Pharma plc Announces the Cancellation of Admission of its Ordinary...
Daniel Carlson
-
November 22, 2021
0
Front Page
Lantern Pharma Announces Share Repurchase Program
Daniel Carlson
-
November 22, 2021
0
Front Page
The Worst Bull Market Ever
Daniel Carlson
-
November 20, 2021
6
Front Page
Trading Blog, November 18th, 2021
Daniel Carlson
-
November 18, 2021
0
Atomera
Atomera Reaches 300 Patents Focused on Perfecting Atomic Level Engineering and...
Daniel Carlson
-
November 17, 2021
0
Front Page
Quest Resource Holding Corp. Reports 3rd Quarter 2021 Financial Results
Daniel Carlson
-
November 16, 2021
0
Fortress Bio
Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent...
Daniel Carlson
-
November 16, 2021
0
Front Page
TFF Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business...
Daniel Carlson
-
November 16, 2021
0
Front Page
Three Non-Biotech Stocks
Daniel Carlson
-
November 12, 2021
4
Fortress Bio
Journey Medical Corporation Prices $35.2 Million Initial Public Offering
Daniel Carlson
-
November 12, 2021
0
Front Page
Lantern Pharma Announces Abstract on Effectiveness of LP-184 in Glioblastoma Accepted...
Daniel Carlson
-
November 11, 2021
0
Front Page
enVVeno Medical Reports Third Quarter 2021 Financial Results and Provides Corporate...
Daniel Carlson
-
November 11, 2021
5
Front Page
QUEST RESOURCE HOLDING CORPORATION ACQUIRES ASSET-LIGHT WASTE SERVICES PROVIDER
Daniel Carlson
-
November 11, 2021
0
Front Page
Notes from INKmune Update
Daniel Carlson
-
November 10, 2021
3
Front Page
Trading Blog, November 9th, 2021
Daniel Carlson
-
November 9, 2021
6
Front Page
LexaGene Expands Bio-Pharma Contamination Panel by Adding Test that includes a...
Daniel Carlson
-
November 9, 2021
0
Front Page
TFF Pharmaceuticals Announces Completion of Dosing of Phase 1b Study for...
Daniel Carlson
-
November 8, 2021
1
Anixa
Asymmetric Risk
Daniel Carlson
-
November 6, 2021
5
Front Page
Lantern Pharma Announces Abstract on Effectiveness of LP-284 in Hematologic Cancers...
Daniel Carlson
-
November 4, 2021
0
Front Page
INmune Bio, Inc. Announces Third Quarter 2021 Results and Provides Business...
Daniel Carlson
-
November 3, 2021
4
Amryt
Amryt Reports Strong Q3 2021 Results
Daniel Carlson
-
November 3, 2021
0
Front Page
ParkerVision Receives Favorable Markman Recommendations in ParkerVision v. Hisense and TCL
Daniel Carlson
-
November 2, 2021
0
Front Page
Lantern Pharma Reports Third Quarter 2021 Financial Results and Operating Highlights
Daniel Carlson
-
November 1, 2021
0
Front Page
Lantern Pharma’s Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®,...
Daniel Carlson
-
November 1, 2021
0
Atomera
Trick or Treat? October Review
Daniel Carlson
-
October 30, 2021
4
Front Page
LexaGene Completes First Stage of U.S. ARMY DEVCOM Agreement
Daniel Carlson
-
October 29, 2021
0
Atomera
Atomera Provides Third Quarter 2021 Results
Daniel Carlson
-
October 28, 2021
0
Front Page
TFF Pharmaceuticals Receives Approval from Health Canada to Enter Human Clinical...
Daniel Carlson
-
October 28, 2021
0
Front Page
Code Ocean Selected by Lantern Pharma to Power A.I. and Computational...
Daniel Carlson
-
October 27, 2021
0
Front Page
INmune Bio, Inc. Announces Multiple Oral and Poster Presentations at the...
Daniel Carlson
-
October 27, 2021
0
Front Page
Trading Blog, October 26th, 2021
Daniel Carlson
-
October 26, 2021
0
Anixa
Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in...
Daniel Carlson
-
October 26, 2021
0
Front Page
LexaGene Completes Analytical Studies for FDA EUA of COVID-19 Testing
Daniel Carlson
-
October 25, 2021
0
Anixa
Training My Thoughts
Daniel Carlson
-
October 22, 2021
0
Front Page
enVVeno Medical Reports Successful Completion of First VenoValve Surgery for U.S....
Daniel Carlson
-
October 22, 2021
0
Amryt
Amryt Announces New Patents for Oleogel-S10 and Mycapssa®
Daniel Carlson
-
October 19, 2021
0
Anixa
Saturday Morning Musings
Daniel Carlson
-
October 16, 2021
6
Front Page
Why TFF’s Hamster Data Is Bigger Than Investors Think
Daniel Carlson
-
October 15, 2021
2
Front Page
Trading Blog, October 14th, 2021
Daniel Carlson
-
October 14, 2021
0
Front Page
TFF Pharmaceuticals and Augmenta Bioworks Publish Positive In Vivo Data Showing...
Daniel Carlson
-
October 14, 2021
0
Front Page
Ondas Holdings Inc. Announces Strategic Partnership with Dynam.AI
Daniel Carlson
-
October 11, 2021
0
Anixa
$8 Paddle Balls?
Daniel Carlson
-
October 9, 2021
2
Fortress Bio
Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101,...
Daniel Carlson
-
October 8, 2021
0
Front Page
LexaGene’s Largest Study Validates Accuracy of its Veterinary Test Panel
Daniel Carlson
-
October 7, 2021
0
Anixa
Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy...
Daniel Carlson
-
October 6, 2021
2
Front Page
Trading Blog, October 5th, 2021
Daniel Carlson
-
October 5, 2021
3
Amryt
October Awaits
Daniel Carlson
-
October 2, 2021
2
Anixa
Anixa Biosciences Announces Notice of Allowance for Additional Patent on its...
Daniel Carlson
-
October 1, 2021
0
Front Page
LexaGene Reports on Recent Veterinary Trade Shows
Daniel Carlson
-
September 30, 2021
0
Fortress Bio
Fortress Biotech Announces Receipt of Notice of Option Exercise from AstraZeneca...
Daniel Carlson
-
September 29, 2021
0
Front Page
Trading Blog, Sept. 28th, 2021
Daniel Carlson
-
September 28, 2021
0
Front Page
Lantern Pharma Enters into Strategic Collaboration with Deep Lens — Partnership...
Daniel Carlson
-
September 28, 2021
0
Front Page
Cash is King
Daniel Carlson
-
September 25, 2021
1
Front Page
TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial...
Daniel Carlson
-
September 23, 2021
1
Front Page
Trading Blog, Sept. 22nd, 2021
Daniel Carlson
-
September 22, 2021
1
Front Page
Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development...
Daniel Carlson
-
September 22, 2021
0
Front Page
Ondas Networks to Present at Annual Railway System Supplier Show
Daniel Carlson
-
September 22, 2021
0
Amryt
When The Tide Goes Out, You See Who’s Swimming Naked…
Daniel Carlson
-
September 18, 2021
6
Front Page
Trading Blog, Sept. 16th, 2021
Daniel Carlson
-
September 16, 2021
6
Front Page
Siemens Mobility to present Airlink Wireless Radio System in Live DemoCast
Daniel Carlson
-
September 16, 2021
0
Anixa
Anixa Biosciences’ Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming...
Daniel Carlson
-
September 14, 2021
0
Amryt
Amryt Raises Full Year 2021 Revenue Guidance to $220M – $225M
Daniel Carlson
-
September 13, 2021
0
Front Page
Rolling Over? Markets Look Toppy To Me…
Daniel Carlson
-
September 11, 2021
1
Front Page
Trade Alert, Sept. 8, 2021
Daniel Carlson
-
September 8, 2021
6
Front Page
Hancock Jaffe Laboratories Announces $20 Million Registered Direct Offering Priced At-the-Market...
Daniel Carlson
-
September 7, 2021
0
Anixa
Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer
Daniel Carlson
-
September 7, 2021
0
Front Page
LexaGene’s MiQLab™ Accurately Detects Multiple Strains of Pathogenic Bacteria in Polymicrobial...
Daniel Carlson
-
September 7, 2021
1
Front Page
ParkerVision Secures Patent License and Settlement Agreement with Zyxel
Daniel Carlson
-
September 7, 2021
0
Anixa
A September To Remember?
Daniel Carlson
-
September 4, 2021
1
Front Page
LexaGene’s MiQLab(TM) System Featured at Three Key Veterinary Tradeshows
Daniel Carlson
-
September 3, 2021
0
Front Page
Lantern Pharma Expands Management Team with Appointment of Two Leading Industry...
Daniel Carlson
-
September 2, 2021
0
Front Page
Alzheimer’s Patients Treated with INmune Bio’s XPro™ Show Reduction in CSF...
Daniel Carlson
-
September 1, 2021
0
Front Page
FDA Grants Lantern Pharma Additional Orphan Drug Designation for Drug Candidate...
Daniel Carlson
-
August 30, 2021
0
Anixa
Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate...
Daniel Carlson
-
August 30, 2021
0
Front Page
Small Caps Rebound…August Recap
Daniel Carlson
-
August 28, 2021
5
Front Page
INKmune Induces Memory-Like NK Cells…This Is A Very Big Deal
Daniel Carlson
-
August 26, 2021
6
Anixa
Anixa Biosciences’ Covid-19 Compounds Expected to be Effective Against the Delta...
Daniel Carlson
-
August 25, 2021
0
Amryt
Old Fashioned Sunday
Daniel Carlson
-
August 21, 2021
5
Front Page
PERFORMANT FINANCIAL CORPORATION ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
Daniel Carlson
-
August 19, 2021
0
Front Page
Lantern Pharma Announces Positive Preclinical Data in Glioblastoma (GBM) with Drug...
Daniel Carlson
-
August 19, 2021
0
Front Page
Hancock Jaffe Presents New Positive Two-Year VenoValve Data at the Society...
Daniel Carlson
-
August 19, 2021
0
Front Page
INKmune: An Interview With INmune Bio’s Dr. Mark Lowdell
Daniel Carlson
-
August 18, 2021
0
Front Page
QUEST RESOURCE HOLDING CORPORATION REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS
Daniel Carlson
-
August 18, 2021
0
Anixa
Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine...
Daniel Carlson
-
August 18, 2021
0
Front Page
Lantern Pharma Announces Abstract on Effectiveness of LP-184 in Pancreatic Cancers...
Daniel Carlson
-
August 16, 2021
0
Front Page
Summer Stocks
Daniel Carlson
-
August 14, 2021
4
Front Page
TFF Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business...
Daniel Carlson
-
August 12, 2021
2
Front Page
LexaGene Demonstrates a Simple and Inexpensive Multiplex PCR Chemistry with Shorter...
Daniel Carlson
-
August 12, 2021
0
Front Page
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-184...
Daniel Carlson
-
August 11, 2021
0
Performant
PERFORMANT FINANCIAL CORPORATION ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER 2021
Daniel Carlson
-
August 10, 2021
0
Amryt
My Saturday Rant…
Daniel Carlson
-
August 7, 2021
4
Front Page
Trading Blog, August 6, 2021
Daniel Carlson
-
August 6, 2021
0
Amryt
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
Daniel Carlson
-
August 6, 2021
0
Front Page
INmune Bio, Inc. Announces Second Quarter 2021 Results and Provides Business...
Daniel Carlson
-
August 4, 2021
0
Front Page
FDA Grants Breakthrough Device Designation Status for Hancock Jaffe’s VenoValve
Daniel Carlson
-
August 3, 2021
0
Amryt
Are We Having Fun Yet? Bull Ride Continues
Daniel Carlson
-
July 31, 2021
6
Front Page
Augmenta Bioworks and TFF Pharmaceuticals Announce Positive In Vitro Data Demonstrating...
Daniel Carlson
-
July 29, 2021
2
Front Page
INmune Bio, Inc. Announces Design of Upcoming Phase 2 Alzheimer’s Disease...
Daniel Carlson
-
July 26, 2021
5
Anixa
July About to Close With a Bang?
Daniel Carlson
-
July 24, 2021
0
Front Page
ParkerVision Receives Second Favorable Markman Ruling in ParkerVision v. Intel
Daniel Carlson
-
July 23, 2021
4
Front Page
Lantern Pharma Announces Significant Positive Preclinical Data in Pancreatic Cancer With...
Daniel Carlson
-
July 20, 2021
0
Front Page
INmune Bio, Inc. Announces Poster Presentation and Plenary Talk at the...
Daniel Carlson
-
July 19, 2021
0
Anixa
Back In The Torture Chamber
Daniel Carlson
-
July 17, 2021
3
Front Page
INmune Bio, Inc. Announces $40 Million Registered Direct Offering
Daniel Carlson
-
July 14, 2021
2
Front Page
TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its...
Daniel Carlson
-
July 13, 2021
4
Front Page
INmune Bio, Inc. Announces First Patient Treated with NK cell priming...
Daniel Carlson
-
July 12, 2021
0
Front Page
Kentucky Bluegrass
Daniel Carlson
-
July 10, 2021
3
Front Page
LexaGene Launches 2nd Generation Bacterial and Drug Resistance Test to Better...
Daniel Carlson
-
July 7, 2021
0
Anixa
Let’s Get Ready To Rumble (2nd Half Preview)
Daniel Carlson
-
July 3, 2021
2
Front Page
LexaGene Advances Towards FDA Emergency Use Authorization
Daniel Carlson
-
July 2, 2021
0
Fortress Bio
Journey Medical Corporation Enters into a Definitive Agreement with Dr. Reddy’s...
Daniel Carlson
-
June 30, 2021
0
Amryt
Hoping for Fireworks
Daniel Carlson
-
June 26, 2021
6
Front Page
Trading Blog, June 24, 2021
Daniel Carlson
-
June 24, 2021
0
Front Page
Augmenta Bioworks and TFF Pharmaceuticals Announce Selection of Lead Monoclonal Antibody...
Daniel Carlson
-
June 22, 2021
1
Front Page
Put The Hammer Down…Backgammon Lessons
Daniel Carlson
-
June 19, 2021
2
Front Page
LexaGene’s MiQLab Offers Rapid Plague Detection for Bioterrorism Threats
Daniel Carlson
-
June 17, 2021
0
Front Page
Warrant Repo Is A Coup For INmune
Daniel Carlson
-
June 15, 2021
1
Front Page
INmune Bio, Inc. Announces $15 Million Credit Facility to Purchase Xencor...
Daniel Carlson
-
June 15, 2021
0
Front Page
QUEST RESOURCE HOLDING CORPORATION ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE ASSET-LIGHT WASTE...
Daniel Carlson
-
June 15, 2021
0
Front Page
LexaGene Closes Sale to Alpine Veterinary Hospital
Daniel Carlson
-
June 14, 2021
0
Amryt
Stock Picking Wins This Week
Daniel Carlson
-
June 12, 2021
8
Fortress Bio
Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and...
Daniel Carlson
-
June 11, 2021
0
Fortress Bio
Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106 CD20-Targeted...
Daniel Carlson
-
June 11, 2021
0
Front Page
LexaGene detects a slow-growing bacterium at least 36-times faster than conventional...
Daniel Carlson
-
June 10, 2021
0
Front Page
Aducanumab Approval…Implications For INmune Bio
Daniel Carlson
-
June 8, 2021
3
Front Page
LexaGene Sells a MiQLab System to Denver Animal Emergency
Daniel Carlson
-
June 7, 2021
0
Front Page
TFF Pharmaceuticals Hosting Key Opinion Leader Perspectives on Thin Film Freezing...
Daniel Carlson
-
June 7, 2021
2
Amryt
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee...
Daniel Carlson
-
June 7, 2021
0
Amryt
Oregon Trails
Daniel Carlson
-
June 4, 2021
2
Front Page
LexaGene Partners with Ethos Discovery to Develop New Companion Animal Diagnostic...
Daniel Carlson
-
June 3, 2021
0
Amryt
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for...
Daniel Carlson
-
June 3, 2021
0
Front Page
INmune Bio, Inc. Announces Lead Drug Candidate XPro1595 Receives Chemical Drug...
Daniel Carlson
-
June 2, 2021
0
Amryt
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for...
Daniel Carlson
-
June 2, 2021
0
Front Page
LexaGene Takes Steps to List on the Nasdaq
Daniel Carlson
-
June 1, 2021
0
Atomera
Resetting Expectations for TFF Pharma
Daniel Carlson
-
May 28, 2021
3
Anixa
Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian...
Daniel Carlson
-
May 26, 2021
0
Front Page
ParkerVision Files Against LG for Patent Infringement
Daniel Carlson
-
May 24, 2021
0
Front Page
Reversal of Fortune
Daniel Carlson
-
May 22, 2021
2
Anixa
Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from...
Daniel Carlson
-
May 20, 2021
0
Front Page
ParkerVision Secures Patent License and Settlement Agreement with Buffalo, Inc.
Daniel Carlson
-
May 19, 2021
0
Front Page
Quest Resource Holding Corporation Reports First Quarter 2021 Financial Results
Daniel Carlson
-
May 18, 2021
0
Fortress Bio
Mustang Bio and City of Hope Announce First Patient Dosed in...
Daniel Carlson
-
May 18, 2021
0
Fortress Bio
Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate...
Daniel Carlson
-
May 17, 2021
0
Anixa
Gas Lines and Inflation…Is This The 80’s?
Daniel Carlson
-
May 15, 2021
6
Front Page
TFF Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business...
Daniel Carlson
-
May 13, 2021
0
Amryt
Opportunity Knocks, Amryt Smartly Acquires Chiasma
Daniel Carlson
-
May 12, 2021
2
Front Page
Summit Wireless Technologies Posts 181% Q1 2021 Revenue Increase and Guides...
Daniel Carlson
-
May 12, 2021
0
Fortress Bio
Checkpoint Therapeutics Announces Completion of Enrollment in the Registration-Enabling Trial of...
Daniel Carlson
-
May 12, 2021
0
Fortress Bio
Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin to Develop...
Daniel Carlson
-
May 11, 2021
0
Front Page
LexaGene Expands Its Sales Team
Daniel Carlson
-
May 11, 2021
0
Amryt
The Beatings Will Continue Until Morale Improves…
Daniel Carlson
-
May 7, 2021
4
Anixa
OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie
Daniel Carlson
-
May 7, 2021
0
Front Page
INmune Bio, Inc. Announces First Quarter 2021 Results and Provides Business...
Daniel Carlson
-
May 5, 2021
0
Amryt
Amryt Reports Record Q1 2021 Financial and Operating Results
Daniel Carlson
-
May 5, 2021
0
Amryt
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership...
Daniel Carlson
-
May 5, 2021
0
Front Page
Lantern Shines During Biotech Blackout
Daniel Carlson
-
May 4, 2021
0
Front Page
Lantern Pharma Reports First Quarter 2021 Financial Results and Operational Highlights
Daniel Carlson
-
May 3, 2021
0
Front Page
Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging...
Daniel Carlson
-
May 3, 2021
0
Anixa
Alpha-Bet Soup
Daniel Carlson
-
May 1, 2021
4
Front Page
Trading Blog, April 30, 2021
Daniel Carlson
-
April 30, 2021
0
Front Page
Trade Alert, April 29th, 2021
Daniel Carlson
-
April 29, 2021
1
Front Page
QUEST® PROGANICS™ PROVIDES A TRANSFORMATIVE STEP FORWARD IN ORGANICS RECYCLING
Daniel Carlson
-
April 29, 2021
0
Front Page
Lantern Pharma’s Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®,...
Daniel Carlson
-
April 29, 2021
0
Front Page
Trading Blog, April 27th
Daniel Carlson
-
April 27, 2021
0
Front Page
Sequans Communications Announces First Quarter 2021 Financial Results
Daniel Carlson
-
April 27, 2021
0
Front Page
Lantern Pharma Announces Publication Detailing Preclinical Results of Drug Candidate, LP-184,...
Daniel Carlson
-
April 26, 2021
0
Anixa
The Lows Appear To Be In Place
Daniel Carlson
-
April 24, 2021
9
Front Page
Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa Presents VenoValve One...
Daniel Carlson
-
April 23, 2021
0
Front Page
XPro1595: A Next-Generation TNF Inhibitor
Daniel Carlson
-
April 21, 2021
4
Anixa
Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of...
Daniel Carlson
-
April 19, 2021
0
Anixa
How Long Can You Hold A Soccer Ball Under Water?
Daniel Carlson
-
April 17, 2021
6
Atomera
Atomera Appoints Sudarsan Srinivasan as Vice President of Engineering
Daniel Carlson
-
April 14, 2021
1
Front Page
LEXAGENE HOSTS A SEMINAR TO PRESENT MIQLAB DATA FROM VETERINARY SAMPLES
Daniel Carlson
-
April 14, 2021
0
Front Page
TFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program...
Daniel Carlson
-
April 13, 2021
0
Front Page
In Defense of INmune
Daniel Carlson
-
April 10, 2021
7
Front Page
First U.S. Patent Issues on Hancock Jaffe VenoValve
Daniel Carlson
-
April 7, 2021
2
Front Page
Sequans Announces $50 Million Financing to Strengthen Balance Sheet
Daniel Carlson
-
April 7, 2021
0
Front Page
Lithe Audio Launches First WiSA Certified Dolby Atmos Ceiling Speakers
Daniel Carlson
-
April 7, 2021
0
Amryt
Amryt Announces the Appointment of Sheila Frame as President Americas
Daniel Carlson
-
April 6, 2021
0
Front Page
Trading Blog, April 6, 2021
Daniel Carlson
-
April 6, 2021
0
Anixa
Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19...
Daniel Carlson
-
April 5, 2021
0
Front Page
Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Pivotal Trial
Daniel Carlson
-
April 5, 2021
0
Amryt
A Catalyst Filled Quarter Lies Around The Corner
Daniel Carlson
-
April 3, 2021
6
Fortress Bio
Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc.,...
Daniel Carlson
-
April 1, 2021
0
Front Page
LEXAGENE PROVIDES CORPORATE UPDATE
Daniel Carlson
-
April 1, 2021
0
Front Page
Lantern Pharma Expands Portfolio of Cancer Opportunities for LP-184 with ATRT...
Daniel Carlson
-
April 1, 2021
0
Amryt
Amryt Submits a New Drug Application to the US Food and...
Daniel Carlson
-
March 31, 2021
0
Amryt
Amryt Announces Results from an Investigator Sponsored Study of Lomitapide in...
Daniel Carlson
-
March 30, 2021
0
Front Page
Orlando Court to Reschedule Trial; Company Raises $3.6 Million in Private...
Daniel Carlson
-
March 29, 2021
0
Amryt
Amryt Announces Validation of its MAA by the EMA for Oleogel-S10*...
Daniel Carlson
-
March 29, 2021
0
Anixa
2nd Degree of Risk
Daniel Carlson
-
March 27, 2021
3
Front Page
TFF Pharmaceuticals Prices Offering of Common Stock
Daniel Carlson
-
March 26, 2021
0
Anixa
This Week’s View On Anixa
Daniel Carlson
-
March 25, 2021
6
Uncategorized
Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock...
Daniel Carlson
-
March 23, 2021
0
Front Page
WiSA Member Foxconn Demos Sharp 120-Inch 8K TV with WiSA SoundSend...
Daniel Carlson
-
March 23, 2021
5
Amryt
Amryt Receives Positive Feedback from the FDA on the Path Forward...
Daniel Carlson
-
March 23, 2021
0
Front Page
Lantern Pharma to Present New Data Supporting the Advancement of LP-184...
Daniel Carlson
-
March 23, 2021
0
Anixa
Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian...
Daniel Carlson
-
March 22, 2021
4
Amryt
Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs...
Daniel Carlson
-
March 22, 2021
0
Anixa
Sitting On My Hands
Daniel Carlson
-
March 20, 2021
3
Front Page
Hisense TVs Certified WiSA Ready™, WiSA’s Interoperability Standard Becoming Must-Have Feature...
Daniel Carlson
-
March 18, 2021
0
Front Page
Lantern Pharma Announces Filing of Seven Patent Applications Globally on Novel...
Daniel Carlson
-
March 17, 2021
0
Anixa
Technically Speaking
Daniel Carlson
-
March 13, 2021
11
Front Page
Recapping TFF’s Shareholder Update Call
Daniel Carlson
-
March 12, 2021
3
Front Page
QUEST RESOURCE HOLDING CORPORATION REPORTS 2020 FINANCIAL RESULTS
Daniel Carlson
-
March 12, 2021
0
Anixa
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian...
Daniel Carlson
-
March 12, 2021
0
Front Page
Platin Audio Debuts Sleek and Powerful New Product Line for Home...
Daniel Carlson
-
March 11, 2021
0
Front Page
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and...
Daniel Carlson
-
March 10, 2021
0
Front Page
Lantern Pharma Reports Fourth Quarter and Year End 2020 Financial Results...
Daniel Carlson
-
March 10, 2021
0
Front Page
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
Daniel Carlson
-
March 9, 2021
0
Front Page
Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine...
Daniel Carlson
-
March 9, 2021
0
Front Page
Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results
Daniel Carlson
-
March 8, 2021
0
Amryt
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in...
Daniel Carlson
-
March 8, 2021
0
Amryt
Blood In The Water
Daniel Carlson
-
March 6, 2021
0
Front Page
Trading Blog, March 5, 2021
Daniel Carlson
-
March 5, 2021
3
Anixa
Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy
Daniel Carlson
-
March 4, 2021
0
Front Page
TFF Pharmaceuticals Provides Update on Clinical Development Programs
Daniel Carlson
-
March 4, 2021
0
Amryt
Amryt (AMYT): A Rare Find in Today’s Market… Growth At A...
Daniel Carlson
-
March 2, 2021
4
Front Page
LEXAGENE RECEIVES $3.6M FROM THE EXERCISE OF WARRANTS
Daniel Carlson
-
March 2, 2021
0
Atomera
Atomera, Inc: Atomera Announces First Customer to Enter Phase 4
Daniel Carlson
-
March 2, 2021
0
Front Page
Keep Looking Forward
Daniel Carlson
-
February 27, 2021
4
Fortress Bio
Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer
Daniel Carlson
-
February 25, 2021
0
Front Page
Trading Blog, Feb. 25th 2021
Daniel Carlson
-
February 25, 2021
4
Fortress Bio
Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a...
Daniel Carlson
-
February 24, 2021
0
Front Page
Miami Advice
Daniel Carlson
-
February 20, 2021
7
Front Page
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for...
Daniel Carlson
-
February 19, 2021
0
Front Page
Trading Blog, Feb. 18th, 2021
Daniel Carlson
-
February 16, 2021
1
Anixa
Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates
Daniel Carlson
-
February 16, 2021
0
Anixa
Heard On The Street
Daniel Carlson
-
February 13, 2021
10
Front Page
LexaGene Announces Change in Management and Appoints New Member to the...
Daniel Carlson
-
February 12, 2021
0
Front Page
HJLI Tried To Ruin 2019 For Me…2021 Should Be A Different...
Daniel Carlson
-
February 10, 2021
10
Atomera
Atomera Provides Fourth Quarter and Fiscal 2020 Results
Daniel Carlson
-
February 10, 2021
0
Front Page
LEXAGENE’S MIQLAB SUCCESSFULLY DETECTS MUTANT UK AND SOUTH AFRICAN COVID-19 SEQUENCES
Daniel Carlson
-
February 10, 2021
0
Front Page
Sequans Communications Announces Fourth Quarter 2020 and Full Year 2020 Financial...
Daniel Carlson
-
February 10, 2021
0
Anixa
Riding the Waves
Daniel Carlson
-
February 6, 2021
4
INmune
Trading Blog: INmune (INMB) and Cassava (SAVA)
Daniel Carlson
-
February 2, 2021
2
Fortress Bio
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the...
Daniel Carlson
-
February 2, 2021
0
Anixa
The GameStop Impact…January In Review
Daniel Carlson
-
January 30, 2021
8
Front Page
Sequans Receives Major Funding Award for 5G Development From French Government
Daniel Carlson
-
January 28, 2021
0
Front Page
ParkerVision Gets Inside Track On Intel In Markman Ruling
Daniel Carlson
-
January 27, 2021
5
Front Page
Trading Blog, Jan. 26, 2021
Daniel Carlson
-
January 27, 2021
0
Front Page
Texas Court’s Markman Ruling Favorable for ParkerVision
Daniel Carlson
-
January 27, 2021
0
Front Page
When Will The Music Stop?
Daniel Carlson
-
January 23, 2021
12
Front Page
INmune…Meaningful Progress in Alzheimer’s Disease
Daniel Carlson
-
January 21, 2021
12
Front Page
INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration...
Daniel Carlson
-
January 21, 2021
0
Front Page
Trade Alert, January 20, 2020
Daniel Carlson
-
January 20, 2021
1
Atomera
Next Up? INmune’s Big Week Finally Arrives
Daniel Carlson
-
January 16, 2021
7
Front Page
Lantern Pharma Announces Pricing of $60 Million Public Offering
Daniel Carlson
-
January 15, 2021
0
Front Page
Summit Wireless Technologies Reports Record Preliminary Revenue of $1.0 Million in...
Daniel Carlson
-
January 14, 2021
0
Front Page
LLY’s $20 Billion Bonanza Bodes Well For INMB
Daniel Carlson
-
January 13, 2021
2
Front Page
Provention Bio Announces Pricing of $100 Million Public Offering of Common...
Daniel Carlson
-
January 13, 2021
0
Front Page
LEXAGENE INITIATES PROGRAM TO IDENTIFY UK AND SOUTH AFRICAN COVID SEQUENCES
Daniel Carlson
-
January 13, 2021
0
Front Page
INmune Bio, Inc. to Host Key Opinion Leader Webinar on Thursday,...
Daniel Carlson
-
January 13, 2021
0
Front Page
Trading Blog, Jan. 12, 2021
Daniel Carlson
-
January 12, 2021
0
Front Page
Muscle Maker Grill Opens Second Ghost Kitchen Location in Philadelphia
Daniel Carlson
-
January 12, 2021
2
Front Page
WiSA Wave Marketing Program Results in Record Consumer Traffic and is...
Daniel Carlson
-
January 12, 2021
0
Anixa
BOOM…Atomera Deal Highlights Another Bull Ride In The Market
Daniel Carlson
-
January 9, 2021
5
Front Page
Renesas and Sequans Expand Their 5G Collaboration Broadband IoT Module for...
Daniel Carlson
-
January 8, 2021
0
Front Page
First Complete Home Cinema Bundles with Hisense TVs, WiSA SoundSend Wireless...
Daniel Carlson
-
January 8, 2021
0
Atomera
ATOM: FOMO Kept Me From Selling, But Is It A Buy?
Daniel Carlson
-
January 7, 2021
5
Front Page
Trading Blog, January 7, 2021
Daniel Carlson
-
January 7, 2021
0
Front Page
Summit Wireless Technologies Launches the First Low-cost IoT Module to Support...
Daniel Carlson
-
January 6, 2021
0
Atomera
Atomera Inks First JDA
Daniel Carlson
-
January 5, 2021
3
Front Page
Lantern Pharma Announces Launch of Antibody Drug Conjugate (ADC) Program to...
Daniel Carlson
-
January 4, 2021
0
Front Page
Provention Bio Announces U.S. FDA Filing of a Biologics License Application...
Daniel Carlson
-
January 4, 2021
0
Front Page
TW’s Top Ten For 2021
Daniel Carlson
-
January 1, 2021
12
Front Page
Muscle Maker Grill Opens the Doors to Their First Ghost Kitchen...
Daniel Carlson
-
January 1, 2021
0
Front Page
Premium Subscriber Trade Alert, December 31, 2020
Daniel Carlson
-
January 1, 2021
2
Front Page
LEXAGENE STARTS FDA EUA STUDY FOR POINT-OF-CARE COVID-19 TESTING
Daniel Carlson
-
December 30, 2020
2
Anixa
Ho Ho Ho, Santa Rally Caps Bizarre Year
Daniel Carlson
-
December 26, 2020
7
Front Page
Trading Blog, December 21, 2020
Daniel Carlson
-
December 21, 2020
1
Fortress Bio
Mustang Bio and City of Hope Announce Initiation of Phase 1...
Daniel Carlson
-
December 21, 2020
0
Anixa
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical...
Daniel Carlson
-
December 21, 2020
0
Atomera
The Squeeze Is On
Daniel Carlson
-
December 18, 2020
3
Front Page
Trading Blog, December 18, 2020
Daniel Carlson
-
December 18, 2020
0
Front Page
Put LP-184, a Potential Blockbuster in the Making, on Your Radar...
Daniel Carlson
-
December 18, 2020
0
Front Page
LexaGene to Place MiQLab Systems at Two Leading Specialty and Emergency...
Daniel Carlson
-
December 17, 2020
0
Front Page
Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at...
Daniel Carlson
-
December 17, 2020
0
Fortress Bio
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
Daniel Carlson
-
December 17, 2020
2
Fortress Bio
Fortress Biotech Announces Breakthrough Therapy Designation for CUTX-101, Copper Histidinate, for...
Daniel Carlson
-
December 15, 2020
0
Front Page
TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation...
Daniel Carlson
-
December 15, 2020
0
Front Page
LexaGene Receives Purchase Order for MiQLab from Ethos Discovery
Daniel Carlson
-
December 15, 2020
2
Front Page
Lantern Pharma Announces Scientific & Preclinical Data Indicating Blood Brain Barrier...
Daniel Carlson
-
December 15, 2020
0
Front Page
Trade Alert, Dec. 14th, 2020
Daniel Carlson
-
December 14, 2020
0
Anixa
Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical...
Daniel Carlson
-
December 14, 2020
1
Fortress Bio
Mustang Bio Announces Interim Phase 1/2 Data for MB-106 in Patients...
Daniel Carlson
-
December 12, 2020
0
Front Page
Changes at TW
Daniel Carlson
-
December 12, 2020
0
Anixa
Climbing The Wall Of Worry…
Daniel Carlson
-
December 12, 2020
4
Front Page
Sequans’ Monarch Module supported by Orange LTE-M Connectivity Now Available
Daniel Carlson
-
December 10, 2020
0
Front Page
Muscle Maker Grill Opens First Partnership Location with REEF Neighborhood Kitchens...
Daniel Carlson
-
December 9, 2020
0
Front Page
JDRF Launches First Mass Screening Program for Early-Stage Type 1 Diabetes...
Daniel Carlson
-
December 8, 2020
0
Atomera
Atomera Announces Availability of MSTcad for Modeling Semiconductor Device Improvements with...
Daniel Carlson
-
December 8, 2020
0
Front Page
SQNS Announces Pricing of Public Secondary Offering of American Depositary Shares
Daniel Carlson
-
December 8, 2020
0
Front Page
Aptose Presents Highlights from ASH and Corporate Update Event
Daniel Carlson
-
December 6, 2020
0
Anixa
The Micro-Cap Rally Continues Full Force
Daniel Carlson
-
December 5, 2020
0
Front Page
Study on Patented Non-Opioid MKO Melt® Reported in Leading Peer-Reviewed Anesthesia...
Daniel Carlson
-
December 3, 2020
0
Front Page
Timing Looks Good For Owning Aptose (APTO)
Daniel Carlson
-
December 3, 2020
0
Anixa
Anixa Adds An Ovarian Cancer Vaccine To Their Portfolio
Daniel Carlson
-
December 1, 2020
0
Anixa
Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer...
Daniel Carlson
-
December 1, 2020
0
Front Page
WiSA’s First Branded Product, SoundSend, Now Available for WiSA Partners, Distributors...
Daniel Carlson
-
November 30, 2020
4
Anixa
Timing Is Everything…Or Is It?
Daniel Carlson
-
November 28, 2020
3
Fortress Bio
Mustang Bio Announces Positive Opinion from the European Medicines Agency on...
Daniel Carlson
-
November 24, 2020
0
Anixa
Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer...
Daniel Carlson
-
November 23, 2020
0
Fortress Bio
Mustang Bio and Minaris Regenerative Medicine Sign Technology Transfer and GMP...
Daniel Carlson
-
November 23, 2020
0
Front Page
A Micro Thanksgiving
Daniel Carlson
-
November 21, 2020
2
Front Page
Trading Ideas Heading Towards Year-End
Daniel Carlson
-
November 19, 2020
0
Front Page
LEXAGENE PLACES MIQLAB SYSTEM AT THE UNIVERSITY OF PENNSYLVANIA’S SCHOOL OF...
Daniel Carlson
-
November 18, 2020
0
Front Page
Lantern Pharma Earnings Call Transcript
Daniel Carlson
-
November 17, 2020
0
Uncategorized
QUEST RESOURCE HOLDING REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
Daniel Carlson
-
November 16, 2020
0
Front Page
Processa Pharmaceuticas Transcript
Daniel Carlson
-
November 16, 2020
0
Front Page
LEXAGENE RECEIVES PURCHASE ORDER FROM A MULTINATIONAL BIOTECHNOLOGY COMPANY
Daniel Carlson
-
November 16, 2020
0
Anixa
The Biden Rally
Daniel Carlson
-
November 14, 2020
2
Front Page
Harrow Health Third Quarter 2020 Letter to Stockholders
Daniel Carlson
-
November 10, 2020
0
Front Page
Pfizer Develops a Vaccine…Implications for Tailwinds
Daniel Carlson
-
November 10, 2020
5
Front Page
ParkerVision Files Against Zyxel and Buffalo for Patent Infringement
Daniel Carlson
-
November 10, 2020
0
Front Page
Summit Wireless Technologies Gains Momentum and Provides Third Quarter 2020 Update
Daniel Carlson
-
November 10, 2020
0
Fortress Bio
Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at...
Daniel Carlson
-
November 9, 2020
0
Front Page
INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial...
Daniel Carlson
-
November 9, 2020
0
Fortress Bio
Moving Week
Daniel Carlson
-
November 7, 2020
3
Front Page
TFFP, INMB, OTRK…Earnings Logjam At Tailwinds
Daniel Carlson
-
November 6, 2020
2
Front Page
INmune Bio, Inc. Announces Third Quarter Results and Provides Business Update
Daniel Carlson
-
November 5, 2020
0
Front Page
TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business Results
Daniel Carlson
-
November 5, 2020
0
Front Page
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a...
Daniel Carlson
-
November 5, 2020
0
Front Page
WiSA Association Expands TV Brand Member List With Rapidly Growing Hisense
Daniel Carlson
-
November 5, 2020
0
Fortress Bio
Mustang Bio Announces MB-106 Data Selected for Presentation at the 62nd...
Daniel Carlson
-
November 4, 2020
0
Front Page
Provention Bio Completes Rolling Submission of the Biologics License Application (BLA)...
Daniel Carlson
-
November 2, 2020
2
Front Page
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide...
Daniel Carlson
-
November 2, 2020
0
Anixa
Sell Mortimer, Sell!!!
Daniel Carlson
-
October 31, 2020
13
Atomera
Atomera Provides Third Quarter 2020 Results
Daniel Carlson
-
October 29, 2020
0
Front Page
Lantern Pharma Reports Third Quarter 2020 Financial Results & Continued Operational...
Daniel Carlson
-
October 29, 2020
0
Front Page
Buoyed by the Boom in New Home Theaters, WiSA Member Platin...
Daniel Carlson
-
October 28, 2020
0
Anixa
Anixa Biosciences to Host Conference Call to Provide Update on Programs
Daniel Carlson
-
October 27, 2020
4
Front Page
Muscle Maker Grill Adds Three New Ghost Kitchen Markets
Daniel Carlson
-
October 27, 2020
0
Front Page
Sequans Communications Announces Third Quarter 2020 Financial Results
Daniel Carlson
-
October 27, 2020
0
Front Page
TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal...
Daniel Carlson
-
October 27, 2020
2
Fortress Bio
Mustang Bio Announces Initial Phase 1 Data on MB-105 for Patients...
Daniel Carlson
-
October 26, 2020
0
Front Page
TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with Experic
Daniel Carlson
-
October 26, 2020
2
Fortress Bio
Time for Small Cap to Shine?
Daniel Carlson
-
October 24, 2020
2
Front Page
Muscle Maker Grill Acquires Manhattan Location
Daniel Carlson
-
October 23, 2020
0
Front Page
Pharmaceutics: Development of Remdesivir as a Dry Powder for Inhalation by...
Daniel Carlson
-
October 23, 2020
0
Front Page
Muscle Maker Grill Signs Agreement Bringing Ghost Kitchens to Miami Beach,...
Daniel Carlson
-
October 22, 2020
0
Front Page
Renesas and Sequans to Collaborate on 5G/4G Cellular IoT
Daniel Carlson
-
October 22, 2020
0
Front Page
Muscle Maker Grill Awarded Contract for Two Locations on Navy Base
Daniel Carlson
-
October 21, 2020
0
Front Page
TFF Firing on All Cylinders; An Update on TAC and CBD
Daniel Carlson
-
October 21, 2020
0
Front Page
QUEST RESOURCE HOLDING CORPORATION ACQUIRES GREEN REMEDIES, STRENGTHENING PRESENCE IN STRATEGIC...
Daniel Carlson
-
October 20, 2020
0
Front Page
TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation...
Daniel Carlson
-
October 20, 2020
0
Front Page
CABRAL GOLD IDENTIFIES NEW HIGH-GRADE TARGET AND PROVIDES RESULTS ON THE...
Daniel Carlson
-
October 20, 2020
0
Anixa
Post Traumatic Investment Disease Redux? Nah, Just A Dose Of Reality
Daniel Carlson
-
October 17, 2020
4
Front Page
Muscle Maker Grill Provides Shareholder Update
Daniel Carlson
-
October 15, 2020
0
